Search results
Results From The WOW.Com Content Network
Metopimazine is an approved prescription drug in France under the brand name Vogalene® [8] that has been used for the treatment of nausea and vomiting. [9] Vogalene® is available under different forms, including 15 mg capsules, 7.5 mg orally disintegrating tablets, 5 mg suppository, 0.1% oral liquid, and a 10 mg/mL intravenous (IV) solution approved for the prevention of chemotherapy-induced ...
The ArabTeX logo. ArabTeX is a free software package providing support for the Arabic and Hebrew alphabets to TeX and LaTeX.Written by Klaus Lagally, it can take romanized ASCII or native script input to produce quality ligatures for Arabic, Persian, Urdu, Pashto, Sindhi, Western Punjabi (Lahnda), Maghribi, Uyghur, Kashmiri, Hebrew, Judeo-Arabic, Ladino and Yiddish.
ArabTeX – adds support for Hebrew and Arabic alphabets [2] FarsiTeX – adds support for Farsi [3] Omega (TeX) – extends multilinguality by using the Basic Multilingual Plane of Unicode; XeTeX – uses Unicode, adds additional fonts [4] TIPA (software) – supports phonetic characters [5] CTeX – Chinese TeX [6] MonTeX – Mongolian LaTeX [7]
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
Iron(III)-hydroxide polymaltose complex is a medication used to treat iron deficiency / iron deficiency anemia and belongs to the group of oral iron preparations.The preparation is a macromolecular complex, consisting of iron(III) hydroxide (trivalent iron, Fe 3+, Fe(OH) 3 ·H 2 O) and the carrier polymaltose and is available in solid form as a film-coated or chewable tablet and in liquid form ...
Tar in dokha was measured at 21.6–45.02 mg/g compared to 1.68–11.87 mg/g in shisha and 5–27 mg/g in cigarettes. [ 3 ] In May 2019, a second study at the University of Sharjah attempted to quantify trace metals in dokha and shisha products, using EDXRF .
The computer program pdfTeX is an extension of Knuth's typesetting program TeX, and was originally written and developed into a publicly usable product by Hàn Thế Thành as a part of the work for his PhD thesis at the Faculty of Informatics, Masaryk University, Brno, Czech Republic.
The FDA approved only the five-mg, twice-daily dose on the grounds that a higher dose was not considered to have an adequate risk-to-benefit ratio. [34] In September 2020, the FDA approved tofacitinib for the treatment of children and adolescents two years of age and older with active polyarticular course juvenile idiopathic arthritis. [35]